A multicenter phase II study of cetuximab in combination with chest radiotherapy and consolidation chemotherapy in patients with stage III non-small cell lung cancer-Reference-Cited by-同舟云学术

A multicenter phase II study of cetuximab in combination with chest radiotherapy and consolidation chemotherapy in patients with stage III non-small cell lung cancer

Published:2013-09 Issue:3 Volume:81 Page:416-421
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Ramalingam S.S.,Kotsakis A.,Tarhini A.A.,Heron D.E.,Smith R.,Friedland D.,Petro D.P.,Raez L.E.,Brahmer J.R.,Greenberger J.S.,Dacic S.,Hershberger P.,Landreneau R.J.,Luketich J.D.,Belani C.P.,Argiris A.

Funder

Lung SPORE

Bristol-Myers Squibb

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference26 articles.

1. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410;Curran;J Natl Cancer Inst,2011

2. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer;Furuse;J Clin Oncol: Off J Am Soc Clin Oncol,1999

3. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

4. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

5. Critical update and emerging trends in epidermal growth factor receptor targeting in cancer;Baselga;J Clin Oncol: Off J Am Soc Clin Oncol,2005

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiotherapy in the management of lung oligometastases;Cancer/Radiothérapie;2024-02

2. Combining radiation and systemic therapy;Palliative Radiation Oncology;2024

3. Safety and Tolerability of Metastasis-Directed Radiation Therapy in the Era of Evolving Systemic, Immune, and Targeted Therapies;Advances in Radiation Oncology;2022-11

4. Consolidation Systemic Therapy in Locally Advanced, Inoperable Nonsmall Cell Lung Cancer—How to Identify Patients Which Can Benefit from It?;Current Oncology;2022-10-31

5. Efficacy and safety of EGFR inhibitors and radiotherapy in locally advanced non-small-cell lung cancer: a meta-analysis;Future Oncology;2022-09